MCT+AE: Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes

Sponsor
Université de Sherbrooke (Other)
Overall Status
Completed
CT.gov ID
NCT02678390
Collaborator
(none)
20
1
2
24
0.8

Study Details

Study Description

Brief Summary

The aim of this study is to compare the effect on ketone production of dietary an MCT supplement combined or not with physical exercise in two groups of women (N=10/group), healthy adults and patients with prediabetes. After an evaluation of the metabolism (a 4-hour visit with multiple blood samples) at the beginning of the study, all the participants are taken for one-week the MCT supplement alone follow by a one-week period of taking the MCT supplement in combination with physical exercise. At the end of each period of time, the 4-hour visit for the evaluation of the metabolism is repeated.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: MCT
  • Dietary Supplement: MCT+ aerobic exercise
  • Dietary Supplement: Aerobic exercise
  • Dietary Supplement: Control day
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Stimulating the Production of Ketones Through the Combined Use of Aerobic Exercise (AE) and Dietary a Medium Chain Triglycerides (MCT) Supplement
Study Start Date :
Sep 1, 2015
Actual Primary Completion Date :
Sep 1, 2017
Actual Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy women

Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days.

Dietary Supplement: MCT
A 5 day consecutive MCT intake of 30 g/day.

Dietary Supplement: MCT+ aerobic exercise
A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days.
Other Names:
  • MCT+AE
  • Dietary Supplement: Aerobic exercise
    A single period of 30 minutes of aerobic exercise (70% to 80% HRR).
    Other Names:
  • AE
  • Dietary Supplement: Control day
    No MCT or aerobic exercise
    Other Names:
  • CTL
  • Experimental: Women with prediabetes

    Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days.

    Dietary Supplement: MCT
    A 5 day consecutive MCT intake of 30 g/day.

    Dietary Supplement: MCT+ aerobic exercise
    A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days.
    Other Names:
  • MCT+AE
  • Dietary Supplement: Aerobic exercise
    A single period of 30 minutes of aerobic exercise (70% to 80% HRR).
    Other Names:
  • AE
  • Dietary Supplement: Control day
    No MCT or aerobic exercise
    Other Names:
  • CTL
  • Outcome Measures

    Primary Outcome Measures

    1. Plasma Ketone Concentrations [5 days]

      Acetoacetate (umol/L) and beta-hydroxybutyrate (umol/L); Called Ketones (µmol/L) when combine together The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)

    Secondary Outcome Measures

    1. Plasma Glucose Concentrations [5 days]

      Glucose (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)

    2. Plasma Triglyceride Concentrations [5 days]

      Triglycerides (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)

    3. Plasma Free Fatty Acid Concentrations [5 days]

      Free fatty acids (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)

    4. Plasma Insulin Concentrations [5 days]

      Insulin (nmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Healthy women group: fasting blood glucose < 6.1 mmol/L and HbA1c < 6.0 %.

    • Women with prediabetes: fasting blood glucose between 6.1 and 6.9 mmol/L and HbA1c between 6.0 and 6.4 %

    Exclusion Criteria:
    • Structured physical activity (more than 2 times per week)

    • Inability to practice physical exercise

    • Diabetes (fasting glucose ≥ 7.0mmol/L or HbA1c ≥ 6.5%)

    • Uncontrolled dyslipidemia or hypertension

    • Use of medications known to affect the metabolism of lipids and carbohydrates (steroids, beta-blockers, diuretics, insulin sensitizers, etc.)

    • Severe infections or inflammations

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Research Centre on Aging - CSSS-IUGS - CIUSSS de l'Estrie - CHUS Sherbrooke Quebec Canada J1H 4C4

    Sponsors and Collaborators

    • Université de Sherbrooke

    Investigators

    • Principal Investigator: Stephen Cunnane, PhD, Research Centre on Aging, CIUSSS de l'Estrie-CHUS

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Université de Sherbrooke
    ClinicalTrials.gov Identifier:
    NCT02678390
    Other Study ID Numbers:
    • 2015-508
    First Posted:
    Feb 9, 2016
    Last Update Posted:
    Apr 7, 2020
    Last Verified:
    Mar 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Period Title: Control (5 Days)
    STARTED 10 10
    COMPLETED 10 10
    NOT COMPLETED 0 0
    Period Title: Control (5 Days)
    STARTED 10 10
    COMPLETED 10 10
    NOT COMPLETED 0 0
    Period Title: Control (5 Days)
    STARTED 10 10
    COMPLETED 10 9
    NOT COMPLETED 0 1
    Period Title: Control (5 Days)
    STARTED 10 9
    COMPLETED 10 9
    NOT COMPLETED 0 0

    Baseline Characteristics

    Arm/Group Title Healthy Women Women With Prediabetes Total
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Total of all reporting groups
    Overall Participants 10 9 19
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    67
    (4)
    68
    (5)
    68
    (4)
    Sex: Female, Male (Count of Participants)
    Female
    10
    100%
    9
    100%
    19
    100%
    Male
    0
    0%
    0
    0%
    0
    0%
    Race and Ethnicity Not Collected (Count of Participants)
    Count of Participants [Participants]
    0
    0%
    Region of Enrollment (participants) [Number]
    Canada
    10
    100%
    9
    100%
    19
    100%
    Body mass index (kg/m2) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [kg/m2]
    27
    (3)
    28
    (4)
    27
    (4)
    Total body fat (% of body fat) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [% of body fat]
    43
    (6)
    40
    (4)
    42
    (5)
    Plasma glucose (mmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [mmol/L]
    5.4
    (0.1)
    6.1
    (0.4)
    5.8
    (0.3)
    Glycated hemoglobin (% of glycated hemoglobin) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [% of glycated hemoglobin]
    5.7
    (0.2)
    6.1
    (0.2)
    5.9
    (0.2)
    Ketones (µmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [µmol/L]
    153
    (94)
    116
    (71)
    135
    (83)
    Triglycerides (mmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [mmol/L]
    1.5
    (0.4)
    1.6
    (0.8)
    1.55
    (0.6)
    Free Fatty acids (mmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [mmol/L]
    0.8
    (0.3)
    0.7
    (0.3)
    0.75
    (0.3)
    Insulin (pmol/L) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [pmol/L]
    64
    (11)
    65
    (32)
    64.5
    (22)

    Outcome Measures

    1. Primary Outcome
    Title Plasma Ketone Concentrations
    Description Acetoacetate (umol/L) and beta-hydroxybutyrate (umol/L); Called Ketones (µmol/L) when combine together The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
    Time Frame 5 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Measure Participants 10 9
    CTL: AUC ketone
    -52
    (117)
    12
    (96)
    MCT: AUC ketone
    493
    (243)
    627
    (489)
    AE: AUC ketone
    122
    (146)
    23
    (74)
    MCT+AE: AUC ketone
    835
    (444)
    663
    (417)
    2. Secondary Outcome
    Title Plasma Glucose Concentrations
    Description Glucose (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
    Time Frame 5 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Measure Participants 10 9
    CTL: AUC glucose
    7.6
    (1.4)
    11.0
    (2.8)
    MCT: AUC glucose
    7.3
    (1.3)
    11.6
    (2.8)
    AE: AUC glucose
    7.6
    (1.0)
    10.4
    (3.0)
    MCT+AE: AUC glucose
    7.7
    (1.5)
    10.3
    (1.8)
    3. Secondary Outcome
    Title Plasma Triglyceride Concentrations
    Description Triglycerides (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
    Time Frame 5 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Measure Participants 10 9
    CTL: AUC triglycerides
    3.6
    (0.6)
    3.8
    (0.3)
    MCT: AUC triglycerides
    3.9
    (0.4)
    3.5
    (0.5)
    AE: AUC triglycerides
    4.0
    (0.4)
    3.7
    (0.7)
    MCT+AE: AUC triglycerides
    3.9
    (0.6)
    3.5
    (0.8)
    4. Secondary Outcome
    Title Plasma Free Fatty Acid Concentrations
    Description Free fatty acids (mmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
    Time Frame 5 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Measure Participants 10 9
    CTL: AUC Free fatty acids
    1.3
    (0.3)
    1.3
    (0.6)
    MCT: AUC Free fatty acids
    1.3
    (0.2)
    1.5
    (0.4)
    AE: AUC Free fatty acids
    1.3
    (0.2)
    1.4
    (0.3)
    MCT+AE: AUC Free fatty acids
    1.4
    (0.6)
    1.6
    (0.3)
    5. Secondary Outcome
    Title Plasma Insulin Concentrations
    Description Insulin (nmol/L) measured in the plasma The area under the curve (AUC) was calculated according to the trapezoidal method from 0 to 4 h during the visits (interventions) CTL = Metabolic study day (Day 1) MCT = Metabolic study day after 5 days of supplementation (Day 5) AE= Metabolic Study day after acute aerobic exercise (Day 6) AE + MCT = Metabolic Study day after 5 days of aerobic exercise and mct supplementation (Day 11)
    Time Frame 5 days

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    Measure Participants 10 9
    CTL: AUC Insulin
    0.9
    (0.5)
    0.8
    (0.3)
    MCT: AUC Insulin
    0.8
    (0.3)
    0.8
    (0.8)
    AE: AUC Insulin
    0.8
    (0.2)
    0.7
    (0.3)
    MCT+AE: AUC Insulin
    0.7
    (0.3)
    0.6
    (0.2)

    Adverse Events

    Time Frame 2 weeks
    Adverse Event Reporting Description
    Arm/Group Title Healthy Women Women With Prediabetes
    Arm/Group Description Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise Arm: Evaluation of MCT, aerobic exercise alone and MCT+ aerobic exercise on glucose/ketone/lipid/insulin metabolism in 4-hour visits with repeated blood sampling. Interventions: A control day with no MCT and no aerobic exercise. A 5 day consecutive MCT intake of 30 g/day. 30 minutes of aerobic exercise at 70% to 80% HRR of intensity. A 5 day consecutive MCT intake of 30 g/day in combination with 30 minutes of aerobic exercise (70% to 80% HRR)/ day for the five days. MCT: A 5 day consecutive MCT intake of 30 g/day. MCT+ aerobic exercise: A 5 day consecutive MCT intake of 30 g/day in combinaison with 30 minutes of aerobic exercise (70% to 80% HRR) per day for the five days. Aerobic exercise: A single period of 30 minutes of aerobic exercise (70% to 80% HRR). Control day: No MCT or aerobic exercise
    All Cause Mortality
    Healthy Women Women With Prediabetes
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/10 (0%) 0/9 (0%)
    Serious Adverse Events
    Healthy Women Women With Prediabetes
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/10 (0%) 0/9 (0%)
    Other (Not Including Serious) Adverse Events
    Healthy Women Women With Prediabetes
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/10 (0%) 0/9 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Pr. Stephen Cunnane
    Organization Research Centre on Aging
    Phone 819-780-2220 ext 45670
    Email stephen.cunnane@usherbrooke.ca
    Responsible Party:
    Université de Sherbrooke
    ClinicalTrials.gov Identifier:
    NCT02678390
    Other Study ID Numbers:
    • 2015-508
    First Posted:
    Feb 9, 2016
    Last Update Posted:
    Apr 7, 2020
    Last Verified:
    Mar 1, 2020